Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation
Cowan, Andrew J., Klippel, Zandra K., Stevenson, Philip A., Hyun, Teresa S., Tuazon, Sherilyn, Becker, Pamela S., Green, Damian J., Holmberg, Leona A., Coffey, David G., Gopal, Ajay K., Libby, EdwardVolume:
23
Language:
english
Journal:
Amyloid
DOI:
10.1080/13506129.2016.1258356
Date:
October, 2016
File:
PDF, 617 KB
english, 2016